GNH USA

Europe — EMA

Lanair

GNH USA supplies Lanair (Montelukast), a leukotriene receptor antagonist for asthma maintenance and allergic rhinitis. Request a quote for global supply.

Montelukast

Request sourcing

1
Pack/s

What is Montelukast?

Montelukast, the active ingredient in Lanair, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to treat asthma maintenance therapy and allergic rhinitis in adults and children.

GNH USA supplies Lanair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Montelukast used for?

Lanair (montelukast) acts on the leukotriene pathway to control chronic airway and nasal inflammation.

Asthma: improves symptom control and reduces the frequency of exacerbations. Allergic rhinitis: relieves nasal congestion, sneezing, itching and rhinorrhea. Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

What are the side effects of Montelukast?

Adverse reactions may range from mild to severe.

Common Side Effects: - Headache - Abdominal pain - Nausea - Dizziness - Cough - Sore throat

Serious or Rare Side Effects: - Angioedema - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Eosinophilic granulomatosis with polyangiitis - Hepatic injury - Severe rash or urticaria - Anaphylaxis

What precautions apply to Montelukast?

Before initiating therapy, consider the following precautions.

Monitor liver function: baseline and periodic tests are recommended. Assess neuropsychiatric symptoms: watch for mood changes, depression or suicidal thoughts. Use with caution in severe renal impairment: dose adjustment may be required. Avoid in patients with known hypersensitivity to montelukast or excipients. Pregnancy and lactation: discuss risk‑benefit with the prescriber. Store at room temperature: keep in the original pack, protect from moisture and heat.

What does Montelukast interact with?

Montelukast may interact with several medicines; monitor as indicated.

Major Interactions (Avoid): - Phenobarbital: may reduce plasma concentrations of montelukast. - Rifampin: enzyme induction can decrease efficacy. - Ketoconazole: may increase montelukast levels, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR; monitor coagulation. - Beta‑agonists: additive bronchodilation effect; observe clinical response. - NSAIDs: may increase risk of hypersensitivity reactions.

Frequently asked questions

What is Lanair used for?+
Lanair contains montelukast, a prescription‑only oral medication indicated for maintenance treatment of asthma, relief of allergic rhinitis symptoms, and prevention of exercise‑induced bronchoconstriction in eligible patients.
How does montelukast work?+
Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotrienes from causing bronchoconstriction, airway edema, and inflammatory cell recruitment, which helps keep the airways open and reduces allergic inflammation.
What is the usual dose of Lanair?+
The specific dose of Lanair is determined by the prescribing healthcare professional based on the patient’s age, weight, indication and clinical response. Dosage forms are typically taken once daily in the evening, but exact strength and regimen must follow the prescriber’s order.
Is Lanair safe during pregnancy or breastfeeding?+
Safety of montelukast in pregnancy and lactation has not been definitively established. Prescribers should weigh potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant, planning pregnancy, or nursing should discuss use with their physician.
How do I order Lanair from GNH USA?+
To request Lanair, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and necessary import documentation.
How does Lanair compare with other asthma medications?+
Compared with inhaled corticosteroids, montelukast offers an oral, once‑daily option that targets leukotriene‑mediated pathways rather than broad anti‑inflammatory effects. It is often used as add‑on therapy when inhaled steroids alone do not achieve control, but it does not replace rescue bronchodilators. Its efficacy is generally modest relative to inhaled steroids for severe asthma.
How should Lanair be stored?+
Store Lanair at room temperature, below 25 °C, in the original packaging. Keep the tablets away from moisture, direct sunlight and heat sources. Do not store in bathrooms or near kitchen appliances. Ensure the container is tightly closed to maintain product stability.
How is Lanair administered?+
Lanair is taken orally, usually as a whole tablet swallowed with water. It is commonly recommended to be taken in the evening to align with the nocturnal rise in leukotriene production, but patients should follow the timing advised by their healthcare provider. Do not crush or chew unless instructed.
What are the most serious risks associated with Lanair?+
Although rare, serious adverse reactions can include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, eosinophilic granulomatosis with polyangiitis, and hepatic injury. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, jaundice, or unexplained fever.
Who should not use Lanair?+
Lanair should be avoided in individuals with known hypersensitivity to montelukast or any of its excipients. Caution is also advised for patients with severe hepatic impairment, and it is not recommended for use as a rescue medication in acute bronchospasm. Pregnant or nursing women should only use it after a risk‑benefit assessment by their physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Montelukast
Route
Oral Use
Manufacturer
G.L. Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU